Skip Nav Destination
Article navigation
January 1987
Conference Abstract|
January 01 1987
Does the Addition of an Oral β2 Agonist (Pirbuterol) to Long Term Oxygen Therapy Yield Further Benefit in Hypoxic Chronic Bronchitis and Emphysema?
W Biernacki;
W Biernacki
1Rayne Laboratory, Department of Respiratory Medicine, University of Edinburgh, City Hospital, Greenbank Drive, Edinburgh
Search for other works by this author on:
KF Whyte;
KF Whyte
1Rayne Laboratory, Department of Respiratory Medicine, University of Edinburgh, City Hospital, Greenbank Drive, Edinburgh
Search for other works by this author on:
K Prince;
K Prince
1Rayne Laboratory, Department of Respiratory Medicine, University of Edinburgh, City Hospital, Greenbank Drive, Edinburgh
Search for other works by this author on:
W MacNee;
W MacNee
1Rayne Laboratory, Department of Respiratory Medicine, University of Edinburgh, City Hospital, Greenbank Drive, Edinburgh
Search for other works by this author on:
DC Flenley
DC Flenley
1Rayne Laboratory, Department of Respiratory Medicine, University of Edinburgh, City Hospital, Greenbank Drive, Edinburgh
Search for other works by this author on:
Clin Sci (Lond) (1987) 72 (s16): 54P–55P.
Citation
W Biernacki, KF Whyte, K Prince, W MacNee, DC Flenley; Does the Addition of an Oral β2 Agonist (Pirbuterol) to Long Term Oxygen Therapy Yield Further Benefit in Hypoxic Chronic Bronchitis and Emphysema?. Clin Sci (Lond) 1 January 1987; 72 (s16): 54P–55P. doi: https://doi.org/10.1042/cs072054Pb
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
2
Views
0
Citations